Ar­row­head re­ports full Phase 2b da­ta for lipid drug, but Io­n­is is a step ahead: #ACC24

Last year
R&D

Io­n­is presents piv­otal rare dis­ease da­ta, builds to­ward first so­lo launch: #ACC24

Last year
R&D

Bris­tol My­ers touts long-term ef­fi­ca­cy of re­cent­ly ac­quired Karuna drug

Last year
R&D

FDA ap­proves J&J and Leg­end’s Carvyk­ti for sec­ond-line mul­ti­ple myelo­ma

Last year
Pharma
Cell/Gene Tx

US-Chi­na ten­sions per­sist; Gen­mab's $1.8B ADC bet; New obe­si­ty start­up in town; ALS drug with­draw­al; and more

Last year
Weekly

FDA grants En­her­tu tu­mor-ag­nos­tic ac­cel­er­at­ed ap­proval

Last year
Pharma
FDA+

Catal­ent had sev­er­al suit­ors, in­clud­ing an­oth­er of its busi­ness part­ners, be­fore No­vo won out

Last year
Deals
Manufacturing

Sanofi to cut jobs in pipeline re­struc­tur­ing

Last year
People
Pharma

Ic­ahn gives up seat on Il­lu­mi­na board, back­ing away from chal­lenge to di­ag­nos­tics com­pa­ny

Last year
Deals
Diagnostics

Loos­en­ing Med­ic­aid re­stric­tions on hep C drugs could im­prove pa­tient ac­cess, study finds

Last year
Pharma
FDA+

Bris­tol My­ers and 2sev­en­ty win la­bel ex­pan­sion for Abec­ma in ear­li­er mul­ti­ple myelo­ma

Last year
Pharma
FDA+

LENZ ral­lies pres­by­opia aware­ness with eye­care pro­fes­sion­als ahead of FDA sub­mis­sion

Last year
Pharma
Marketing

As­traZeneca un­veils pos­i­tive Phase 3 da­ta to move Imfinzi in­to ear­li­er stages of lung can­cer

Last year
R&D
Pharma

Pro­tara's $45M place­ment; Plus, news about Eu­prax­ia and Gen­Sight

Last year
News Briefing

Teladoc's long-time CEO is leav­ing

Last year
People
Health Tech

For­eign in­vestors fled Chi­nese biotech af­ter the pan­dem­ic. They still haven’t come back

Last year
Financing
China

J&J buys an­oth­er medtech com­pa­ny in $13.1B Shock­wave deal

Last year
Deals
Pharma

Aca­dia snags Am­gen, Hori­zon vet to di­rect R&D; Saman­tha Truex steps down as Up­stream Bio CEO

Last year
People
Peer Review

Clock for FTC’s re­view of No­vo Hold­ings' $16.5B Catal­ent buy restarts af­ter re­fil­ing

Last year
Deals
Manufacturing

‘Look be­fore you leap’: Cari­bou to start Ph1 au­toim­mune study of CAR-T ther­a­py

Last year
R&D
Cell/Gene Tx

Con­tineum prices $110M IPO as IPF and neu­ro drugs ad­vance

Last year
Financing
Startups

US-Chi­na ten­sions threat­en to en­snare ad­di­tion­al Chi­nese bio­phar­ma con­trac­tors

Last year
China
Pharma

Am­gen taps Tik­Tok trends, orig­i­nal con­tent and ‘su­per fan’ em­ploy­ees in its so­cial me­dia strat­e­gy

Last year
Pharma
Marketing

No­var­tis plots new Plu­vic­to fil­ing time­line af­ter wait­ing for over­all sur­vival re­sults

Last year
R&D
First page Previous page 175176177178179180181 Next page Last page
A service from the Financial Times